BIIB Related Analyst EPS Change

May 1, 2013 07:20 AM Goldman Sachs Downgrades Biogen (BIIB) to Neutral, Removes from CL List

Apr 26, 2013 08:03 AM Jefferies Lifts Numbers on Biogen (BIIB) Post Q1

Mar 28, 2013 09:12 AM Biogen (BIIB) Target Raised to $215 at Jefferies after Tecfidera Approved with Favorable Label

Sep 10, 2012 12:37 PM UPDATE: UBS Downgrades Biogen (BIIB) to Neutral; Risk/Reward Now Balanced

Jul 25, 2012 01:29 PM UBS Maintains a 'Buy' on Biogen (BIIB); Key Takeaways from 2Q12

Jul 25, 2012 10:05 AM Jefferies Maintains a 'Buy' on Biogen (BIIB) on Strong Q2; Adjusting Numbers

May 9, 2012 12:38 PM UBS Maintains a 'Buy' on Biogen (BIIB); Core Franchise Support Valuation; Pipeline Provides Upside Risk

May 1, 2012 03:58 PM Baird Maintains a 'Neutral' on Biogen (BIIB); Still Prefer the Sidelines as Pipeline Remains The Focus

Apr 19, 2012 10:38 AM Baird Maintains a 'Neutral' on Biogen (NASDAQ: BIIB); Raising Estimates Ahead of Earnings